ZHAO Daming, GAO Mingyang, TU Caixia. Plasma and Skin Tissue Fluid Levels of beta-endorphin in Patients with Vitiligo[J].Chinese Journal of Dermatology, 2001, 34(6): 430-431.
[1] Eedy DJ. Neuropeptides in skin. Br J Dermatol. 1993. 128:597-605. [2] Grimes PE. Halder RM, Jones C, et al. Autoantibodies and their clinical significance in a black vitiligo population. Arch Dermatol.1983, 119:300-303. [3] Berczi I, Chalmers IM, Nagy E, et al. The immune effects of neuropeptides. Baillieres Clin Rheumatol, 1996, 10:227-257. [4] 全国中西医结合皮肤性病学会色素病学组.白癜风临床分型及疗效标准(草案).中华皮肤科杂志,1995,28:212. [5] Dalayeun JF, Nores JM, Bergal S. Physiology of beta-endorphins. A close-up view and a review of the literature. Biomed Pharmacother,1993,47:311-320. [6] Mozzanica N, Villa ML, Foppa S, et al. Plasma alpha-melanocyte-stimulating hormone, beta-endorphin, met-enkephalin, and natural killer cell activity in vitiligo. J Am Acad Dermatol, 1992, 26:693-700. [7] Jessop DS. Beta-endorphin in the immune system-mediator of parn and stress? Lancet, 1998, 351:1828-1829. [8] Morch H, Pedersen BK. Beta-endorphin and the immune system-possible role in autoimmune diseases. Autoimmunity. 1995. 21:161-171.